Sustained release formulation of naltrexone

Sustained release formulation of naltrexone

A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MCKINNEY ANTHONY A, SOLTERO RICHARD, TOLLEFSON GARY D, DUNZO THEA ELISE
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MCKINNEY ANTHONY A
SOLTERO RICHARD
TOLLEFSON GARY D
DUNZO THEA ELISE
description A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9107837B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9107837B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9107837B23</originalsourceid><addsrcrecordid>eNrjZNAOLi0uSczMS01RKErNSU0sTlVIyy_KLc1JLMnMz1PIT1PIS8wpKUqtyM9L5WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8aHBloYG5hbG5k5GxkQoAQBPSCnA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Sustained release formulation of naltrexone</title><source>esp@cenet</source><creator>MCKINNEY ANTHONY A ; SOLTERO RICHARD ; TOLLEFSON GARY D ; DUNZO THEA ELISE</creator><creatorcontrib>MCKINNEY ANTHONY A ; SOLTERO RICHARD ; TOLLEFSON GARY D ; DUNZO THEA ELISE</creatorcontrib><description>A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150818&amp;DB=EPODOC&amp;CC=US&amp;NR=9107837B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150818&amp;DB=EPODOC&amp;CC=US&amp;NR=9107837B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCKINNEY ANTHONY A</creatorcontrib><creatorcontrib>SOLTERO RICHARD</creatorcontrib><creatorcontrib>TOLLEFSON GARY D</creatorcontrib><creatorcontrib>DUNZO THEA ELISE</creatorcontrib><title>Sustained release formulation of naltrexone</title><description>A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAOLi0uSczMS01RKErNSU0sTlVIyy_KLc1JLMnMz1PIT1PIS8wpKUqtyM9L5WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8aHBloYG5hbG5k5GxkQoAQBPSCnA</recordid><startdate>20150818</startdate><enddate>20150818</enddate><creator>MCKINNEY ANTHONY A</creator><creator>SOLTERO RICHARD</creator><creator>TOLLEFSON GARY D</creator><creator>DUNZO THEA ELISE</creator><scope>EVB</scope></search><sort><creationdate>20150818</creationdate><title>Sustained release formulation of naltrexone</title><author>MCKINNEY ANTHONY A ; SOLTERO RICHARD ; TOLLEFSON GARY D ; DUNZO THEA ELISE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9107837B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MCKINNEY ANTHONY A</creatorcontrib><creatorcontrib>SOLTERO RICHARD</creatorcontrib><creatorcontrib>TOLLEFSON GARY D</creatorcontrib><creatorcontrib>DUNZO THEA ELISE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCKINNEY ANTHONY A</au><au>SOLTERO RICHARD</au><au>TOLLEFSON GARY D</au><au>DUNZO THEA ELISE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Sustained release formulation of naltrexone</title><date>2015-08-18</date><risdate>2015</risdate><abstract>A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9107837B2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Sustained release formulation of naltrexone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T00%3A52%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCKINNEY%20ANTHONY%20A&rft.date=2015-08-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9107837B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true